Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Chemotherapy Utilizing Carboplatin, Vincristine, Cyclophosphamide and Etoposide for the Treatment of Central Nervous System Primitive Neurectodermal Tumors of Childhood

NCT00003859 is registered in ClinicalTrials.gov with Societe Internationale d'Oncologie Pediatrique as lead sponsor.

NCT NCT00003859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Chemotherapy Utilizing Carboplatin, Vincristine, Cyclophosphamide and Etoposide for the Treatment of Central Nervous System Primitive Neurectodermal Tumors of Childhood
Lead sponsor
Societe Internationale d'Oncologie Pediatrique
Phase
Phase 3
Overall status
Completed
Start date
April 30, 1992
Completion date
April 30, 2003
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors